North East and North Cumbria
ICS Formulary
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Recent Updates - Updated items
All Formulary Amendments
Records 1 to 30 of 86
Older
Oldest
Details
UPD
sitematrix Changed from 0 to
09/07/2023 21:36:41
(dmcdermott )
UPD
FurtherInformation Changed from
For the treatment of locally advanced or metastatic squamous nonsmall cell lung cancer (NSCLC) after prior chemotherapy in adults.
Approved for the treatment of advanced (unresectable or metastatic)
09/07/2023 21:36:41
(dmcdermott )
UPD
Nivolumab (Opdivo
®
) 876
09/07/2023 21:36:41
(dmcdermott )
LDL
Link Added : NICE TA876: Nivolumab with chemotherapy for neoadjuvant treatment of resectable non-small-cell lung cancer : https://www.nice.org.uk/guidance/ta876
09/07/2023 21:35:42
(dmcdermott )
UPD
sitematrix Changed from 0 to
09/07/2023 21:12:23
(dmcdermott )
UPD
FurtherInformation Changed from
For the treatment of locally advanced or metastatic squamous nonsmall cell lung cancer (NSCLC) after prior chemotherapy in adults.
Approved for the treatment of advanced (unresectable or metastatic)
09/07/2023 21:12:23
(dmcdermott )
UPD
Nivolumab (Opdivo
®
) extra nice ta865
09/07/2023 21:12:23
(dmcdermott )
LDL
Link Added : NICE TA865: Nivolumab with fluoropyrimidine- and platinum-based chemotherapy for untreated unresectable advanced, recurrent, or metastatic oesophageal squamous cell carcinoma : https://www.nice.org.uk/guidance/ta865
09/07/2023 21:10:26
(dmcdermott )
LDL
Link Added : MHRA Drug Safety Update (Oct 2019): Nivolumab (Opdivo): reports of cytomegalovirus (CMV) gastrointestinal infection or reactivation : https://www.gov.uk/drug-safety-update/nivolumab-opdivo-reports-of-cytomegalovirus-cmv-gastrointestinal-infec
06/07/2023 14:18:37
(rpaylor )
LDL
Link Added : MHRA Drug Safety Update (July 2017): Nivolumab (Opdivo▼), pembrolizumab (Keytruda▼): reports of organ transplant rejection : https://www.gov.uk/drug-safety-update/nivolumab-opdivo-pembrolizumab-keytruda-reports-of-organ-transplant
06/07/2023 14:18:11
(rpaylor )
LDL
Link Added : NICE TA724: Nivolumab with ipilimumab and chemotherapy for untreated metastatic non-small- cell lung cancer : https://www.nice.org.uk/guidance/ta724
06/07/2023 14:17:43
(rpaylor )
LDL
Link Added : NICE TA530: Nivolumab for treating locally advanced unresectable or metastatic urothelial cancer after platinum-containing chemotherapy : https://www.nice.org.uk/guidance/ta530
06/07/2023 14:17:17
(rpaylor )
LDL
Link Added : NICE TA713: Nivolumab for advanced non-squamous non-small-cell lung cancer after chemotherapy : https://www.nice.org.uk/guidance/ta713
17/11/2022 14:18:33
(DavidS )
UPD
sitematrix Changed from 0 to
17/11/2022 14:18:08
(DavidS )
UPD
FurtherInformation Changed from
For the treatment of locally advanced or metastatic squamous nonsmall cell lung cancer (NSCLC) after prior chemotherapy in adults.
Approved for the treatment of advanced (unresectable or metastatic)
17/11/2022 14:18:08
(DavidS )
UPD
Nivolumab (Opdivo
®
) NICE TA713
17/11/2022 14:18:08
(DavidS )
LDL
Link Added : NICE TA818: Nivolumab with ipilimumab for untreated unresectable malignant pleural mesothelioma : https://www.nice.org.uk/guidance/ta818
15/11/2022 16:42:22
(DavidS )
UPD
sitematrix Changed from 0 to
15/11/2022 16:42:01
(DavidS )
UPD
FurtherInformation Changed from
For the treatment of locally advanced or metastatic squamous nonsmall cell lung cancer (NSCLC) after prior chemotherapy in adults.
Approved for the treatment of advanced (unresectable or metastatic)
15/11/2022 16:42:01
(DavidS )
UPD
Nivolumab (Opdivo
®
) NICE TA818
15/11/2022 16:42:01
(DavidS )
LDL
Link Added : NICE TA817: Nivolumab for adjuvant treatment of invasive urothelial cancer at high risk of recurrence : https://www.nice.org.uk/guidance/ta817
15/11/2022 16:33:19
(DavidS )
UPD
sitematrix Changed from 0 to
15/11/2022 16:32:57
(DavidS )
UPD
FurtherInformation Changed from
For the treatment of locally advanced or metastatic squamous nonsmall cell lung cancer (NSCLC) after prior chemotherapy in adults.
Approved for the treatment of advanced (unresectable or metastatic)
15/11/2022 16:32:57
(DavidS )
UPD
Nivolumab (Opdivo
®
) NICE TA817
15/11/2022 16:32:57
(DavidS )
UPD
Published from Draft Mode
27/07/2022 16:23:41
(LoweryM )
UPD
sitematrix Changed from 0 to
27/07/2022 14:51:26
(DavidS )
UPD
BlueTeq Changed from N to Y
27/07/2022 14:51:26
(DavidS )
UPD
Nivolumab (Opdivo
®
) updated
27/07/2022 14:51:26
(DavidS )
UPD
sitematrix Changed from 0 to
27/07/2022 14:39:56
(DavidS )
UPD
Nivolumab (Opdivo
®
) brand name added
27/07/2022 14:39:56
(DavidS )